Overexpression of S100B in the mice brain is known to accelerate neurodegenerative disease pathology, including AD and PD [4], [51], and promote the synthesis of APP mRNA and APP in neurons, which could serve as a source of additional Aβ accumulation [52]–[55]. This evidence concerns the gene APP and Alzheimer disease.